Financial Performance - Gross revenue for the year ended December 31, 2023, was CAD 957,725 thousand, an increase of 31.2% from CAD 729,694 thousand in 2022[30] - Net revenue for 2023 was CAD 909,006 thousand, up 27.7% from CAD 712,197 thousand in 2022[30] - The company reported a net loss of CAD 176,551 thousand for 2023, compared to a net loss of CAD 372,428 thousand in 2022, indicating a 52.7% improvement[30] - The company experienced a gross profit of CAD 190,415 thousand in 2023, compared to CAD 140,375 thousand in 2022, reflecting a 35.7% increase[30] - Adjusted EBITDA from continuing operations for the year was 29,205,000,withliquorretailcontributing61,739,000 and cannabis retail operations showing a loss of 12,425,000[37]−ThetotaloperatinglossfortheyearendedDecember31,2023,was162,818,000, primarily driven by cannabis operations which reported a loss of 112,445,000[41]−AdjustedoperatingincomefortheyearendedDecember31,2023,wasalossof97,675,000, with liquor retail showing a positive adjusted operating income of 24,630,000[41]−Thecompanyincurredrestructuringcostsof19,573,000 for the year ended December 31, 2023, impacting overall profitability[41] - Depreciation and amortization expenses for the year totaled 60,216,000,withliquorretailaccountingfor35,662,000[36] Cash Flow and Liquidity - Cash and cash equivalents at the end of 2023 were CAD 195,041 thousand, a decrease of 30.3% from CAD 279,586 thousand at the end of 2022[33] - Free cash flow for Q4 2023 was 1.383million,adecreaseof8710.584 million in Q4 2022[44] - Full-year free cash flow for 2023 was negative at (60.883)million,comparedto(31.900) million in 2022[44] - The change in cash and cash equivalents for Q4 2023 was (6.942)million,animprovementfrom(11.841) million in Q4 2022[44] - Total cash used for common share repurchases in 2023 was 1.536million,downfrom13.390 million in 2022[44] - Cash provided by long-term investments in Q4 2023 was 8.325million,comparedto17.693 million in Q4 2022[44] - The company had no cash used for acquisitions in Q4 2023, while it recorded (2.509)millioninQ42022[44]−Totalcashusedforchangestodebtinstrumentswas0 in 2023, compared to 10millionin2022[44]−Thecompanyreportedatotalchangeincashandcashequivalentsof(84.545) million for the full year 2023, an improvement from (278.665)millionin2022[44]−Thecompanyaimstoenhanceitsfinancialperformancebyfocusingonfreecashflowasakeymetricforinvestors[43]−Thecompanycontinuestoevaluateitsoperationalcashflowsbyexcludingnon−operationalcashusesinitsfreecashflowcalculation[43]StrategicInitiatives−Thecompanyaimstoachievesustainable,positivegrossmarginsandpositivefreecashflowinthefuture[28]−Thecompanyplanstoexpanditsproductofferings,includingtheexpectedexpansionofitswineprivatelabel[28]−ThecompanyisfocusedonstrategiccapitaldeploymentthroughinvestmentsandpartnershipsintheNorthAmericancannabisindustry[27]AssetManagement−TotalassetsdecreasedtoCAD1,473,164thousandasofDecember31,2023,downfromCAD1,559,350thousandin2022[31]−Thecompanyrecognizedanassetimpairmentof54,967,000, with cannabis operations contributing significantly to this figure[37] - For the year ended December 31, 2023, the total net loss from continuing operations was 172,016,000,withsignificantlossesincannabisoperationsamountingto112,159,000[36] Other Financial Metrics - The company reported a net loss of 85,423,000forthethreemonthsendedDecember31,2023,withcannabisretailoperationsincurringalossof65,434,000[37] - For the three months ended December 31, 2023, the company reported an adjusted EBITDA of 3,479,000,withliquorretailcontributing17,812,000[38] - The change in fair value of biological assets resulted in a gain of $7,936,000 for the year, indicating potential growth in cannabis operations[37]